Tips don magance Tsakanin Ƙungiyar Interferon

Ga wasu matakai don yin jituwa tare da sakamako masu tasiri na interferon. Abin takaici, wani matsayi mai mahimmanci na interferon, wanda aka fi sani da interferon-alfa2b (IFN), a halin yanzu ne kawai magani da aka amince ga marasa lafiya marasa lafiya a babban hadarin komawa bayan tiyata. Yawancin cututtuka masu tsanani sun ruwaito daga wadanda ke shan IFN, ciki har da matsalolin fata, tsokoki, ciki, zuciya, koda, hanta da jini.

Wasu sakamako masu illa, irin su gajiya, zasu iya zama har tsawon shekara da aka dauki IFN. Ga wasu matakai masu sauki wanda zai taimake ka ka magance wannan magani mai ƙalubalantar:

Fuka-kamar cututtukan cututtuka

Rashin kamuwa da cututtuka (zazzabi, ciwon zuciya, ciwon kai, ciwon tsoka, tashin zuciya, vomiting) yana kusa da kimanin sa'o'i 12 zuwa bayan karbar kashi na IFN. Abin farin ciki, jikinka zai inganta haƙuri a tsawon lokaci kuma alamun bayyanar za su ragu sosai. Yin amfani da kwayoyin cutar (irin su Tylenol), kwayoyi masu kare kwayoyi (wanda ake kira "anti-emetics"), ko kuma kwayoyi masu kare cututtuka (kamar aspirin, Advil, da naproxen) kafin injecting IFN zai iya rage yawan waɗannan bayyanar cututtuka. Ruwan ruwa mai yawa (lita biyu, ko rabin galan, kowace rana) na iya taimaka.

Wulo

Rashin haɗari shine sakamako na kowa na IFN kuma an bayar da rahoton a cikin 70 zuwa 100 bisa dari na marasa lafiya. Yana ci gaba da ƙaruwa sosai yayin da ci gaba ya ci gaba kuma yana iya zama mai haɗari.

Don taimakawa wajen tafiyar da gajiya naka, ya kamata ka ci abinci mai kyau, daidaitaccen abincin abincin, madaidaicin tsakanin lokutan hutawa da aiki, ƙara yawan ayyukan da kake ciki na motsa jiki da motsa jiki, tsara abubuwan da suka fi ƙarfin aiki a lokacin karfin makamashi, kuma tabbatar da sha ruwa mai yawa.

Rashin Lura

Marasa lafiya waɗanda ake bi da su tare da IFN sukan kokawa game da rashin ci abinci, asarar nauyi da kuma jin "cike" ba da daɗewa ba bayan da ya fara cin abinci.

Duk da haka, tun da abinci mai kyau ya zama mahimmanci don samun damar kammala cikakken hanyar maganin tsoma baki, ya kamata ka gwada ci kananan, abinci mai yawa, yin amfani da karin kariya, kuma ka dauki multivitamins. Kuma kada ku ji kunya game da tambayar iyali ko abokai don taimakawa wajen shirya abinci!

Kwayar cututtuka na tunanin mutum

Mafi yawan lokuta da aka ruwaito rashin lafiyar cutar na asibiti na IFN sune damuwa da rashin jin daɗi, amma kuma yawanci sune rashin tausayi, damuwa da barci, rawar jiki, rashin cin zarafin jima'i, ƙwaƙwalwar ajiyar zuciya, alamar cututtukan mutum, rashin tausin zuciya, da kuma tunanin suicidal. Faɗa wa likitan ku ko likita idan kun ji damu sosai don kuyi amfani da kwayoyin antidepressant (irin su citalopram, escitalopram, fluoxetine, paroxetine, ko sertraline). A gefe guda, idan ka fuskanci mania, bayyanar cututtuka, ko canje-canje mai tsanani, zaka iya buƙatar shawara ta gaggawa tare da likita.

Hanyoyin da ke ciki

Kwararka zai lura da aikin hanta a lokacin gwamnatin IFN. Ka daina shan barasa ko shan duk wani likita ko magungunan likita (irin su Lipitor ko Zocor). Idan kana shan acetaminophen, tabbas za ku kasance da shawarar da aka ba da shawarar.

Yin aiki a lokacin Far

Rashin kamuwa da kamuwa da cututtuka tare da IFN yana da wuya ga mutanen da ke neman ayyukan da suke buƙatar kulawa, musamman ga sufuri da ma'aikata masu nauyi, masu gwagwarmaya, da direbobi da motoci.

Wa] anda ke da nauyin wa] annan ayyuka dole ne a gargadi kan karbar cikakken bukatun da suke da shi yayin da ke kula da lafiyar IFN. Ga mafi yawancin mutane, yana yiwuwa a ci gaba da ayyukanka na yau da kullum yayin ci gaba da kulawa.

Domin IFN ya kasance mai tasiri sosai, yin amfani da cikakken tsawon shekaru yana da mahimmanci. Wajibi ne a gano su kuma a bi da su da sauri kafin su kara tsanani, don haka tabbatar da kasancewa a kusa da ƙwararren likitan ku ko likita.

Magana:

Hauschild A, Gogas H, Tarhini A, Middleton MR, Testori A, Dréno B, Kirkwood JM. "Tsarin shawarwari na tsararre-rikice game da cututtukan da ke hade da maganin interferon-alfa." Ciwon daji . 2008 Mar 1; 112 (5): 982-94.